MPP – Biovac, mRNA Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:October 8, 2024 Post category: Continue ReadingMPP – Biovac, mRNA Vaccine Technology Transfer Agreement
CEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement Post author:GHIAA Admin Post published:September 2, 2024 Post category: Continue ReadingCEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement
Gates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement Post author:GHIAA Admin Post published:July 15, 2024 Post category: Continue ReadingGates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement
NIAID – AbCellera, COVID-19 Exclusive Patent License Agreement Post author:GHIAA Admin Post published:April 11, 2024 Post category: Continue ReadingNIAID – AbCellera, COVID-19 Exclusive Patent License Agreement
India Department of Biotechnology (DBT), Memorandum of Agreement Post author:GHIAA Admin Post published:April 8, 2024 Post category: Continue ReadingIndia Department of Biotechnology (DBT), Memorandum of Agreement
Wellcome Trust Standard Grant Terms & Conditions Post author:GHIAA Admin Post published:February 19, 2024 Post category: Continue ReadingWellcome Trust Standard Grant Terms & Conditions
Medigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement Post author:GHIAA Admin Post published:October 10, 2023 Post category: Continue ReadingMedigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
Gates Foundation – Visterra, Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:September 19, 2023 Post category: Continue ReadingGates Foundation – Visterra, Strategic Relationship Letter Agreement
CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement